Top Industry Leaders in the Cardiac Imaging Software Market

-
October 2023: The Allia IGS Pulse has been given 510(k) approval by the Food and Drug Administration (FDA) for use in complicated cardiology interventional procedures, where it is intended to assist optimal imaging quality and dosage. According to GE HealthCare, the monopolar X-ray tube used in the Allia IGS Pulse allows for silent operation and steep angulation, both of which improve the visibility of coronary artery architecture. Other advantages of the Allia IGS Pulse mentioned by GE HealthCare include the optimization of seven key imaging parameters, including focal spot shape, with the artificial intelligence (AI) leveraging image chain technology AutoRight PLUS, and strong image quality for patients with a BMI greater than 30.
-
June 2023: Increasing patient access to cardiac care, UltraSight, a digital health pioneer transforming cardiac imaging with the power of artificial intelligence, has announced a partnership with point-of-care ultrasound innovator EchoNous. This partnership was announced at ASE 2023, the world's largest gathering of echo specialists. We can get closer to our goal of improving cardiac care equity for patients all over the world if more healthcare professionals in more care settings are able to do cardiac ultrasonography. With the purpose of bringing chronic cardiac patient monitoring closer to patients, UltraSight's real-time AI guiding software will be combined with EchoNous' KOSMOS portable ultrasound equipment.
List of Cardiac imaging software Key companies in the market
- Koninklijke Philips N.V. (Netherlands)
- FUJIFILM Corporation (Japan)
- Siemens (Germany)
- GE Healthcare (US)
- Canon Inc. (US)
- NeoSoft LLC (Pawaukee WI)
- Arteys (US)
- Pie Medical Imaging (Netherlands)
- Medis Medical Imaging (Netherlands)
- Circle Cardiovascular Imaging Inc (Canada)
- Symphony Innovation LLC (US)